Blockchain Registration Transaction Record

Cybin Expands Strategic Partnerships for Phase 3 Trial of CYB003 in Major Depressive Disorder

Cybin expands strategic partnerships for Phase 3 trial of CYB003 in major depressive disorder, signaling progress in revolutionizing mental healthcare with innovative treatment options for mental health conditions.

Cybin Expands Strategic Partnerships for Phase 3 Trial of CYB003 in Major Depressive Disorder

This news matters as Cybin's expansion of clinical sites for its psychedelic-based therapy trial signifies progress in revolutionizing mental healthcare. The strategic partnerships aim to provide innovative treatment options for those with mental health conditions, potentially offering hope to individuals suffering from major depressive disorder and generalized anxiety disorder.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xfbc10e71282484e1b343620c335c2502b6a3b86e7fdda8f6f0df01c3494c63bf
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprinteachyxF7-14ff023f612b8a6781162733ad8d6c33